Tom Lynch: Fred Hutchinson Cancer Center expands immunotherapy offerings

Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared a post by Tom Lynch, President and Chief Executive Officer at Fred Hutch, on X:

“Excited about the expansion efforts and the future of immunotherapy at Fred Hutch Cancer Centre.”

Quoting Tom Lynch‘s post:

“I look forward to continue working with Mazyar Shadman as we expand Fred Hutchinson Cancer Center’s immunotherapy offerings by minimizing wait times, providing universal access to CAR T cell therapy and bringing the most promising clinical trials to our patients.”

Source: Mazyar Shadman/X and Tom Lynch/X